Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study.
Saved in:
| Title: | Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study. |
|---|---|
| Authors: | Chun SJ; Department of Radiation Oncology, Ilsan Dongguk University Hospital, Goyang, the Republic of Korea., Kim N; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea., Lim DH; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea., Kim JY; Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, the Republic of Korea., Wee CW; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea.; Brain Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea., Yoon HI; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea.; Brain Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea., Jeon SH; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, the Republic of Korea., Kim IA; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, the Republic of Korea., Lee JH; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, the Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, the Republic of Korea. |
| Source: | Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2026 May 26; Vol. 59, pp. 101197. Date of Electronic Publication: 2026 May 26 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Ireland Ltd. on behalf of European Society for Radiotherapy and Oncology Country of Publication: Ireland NLM ID: 101713416 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-6308 (Electronic) Linking ISSN: 24056308 NLM ISO Abbreviation: Clin Transl Radiat Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42255978 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chun+SJ%22">Chun SJ</searchLink>; Department of Radiation Oncology, Ilsan Dongguk University Hospital, Goyang, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+N%22">Kim N</searchLink>; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lim+DH%22">Lim DH</searchLink>; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JY%22">Kim JY</searchLink>; Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Wee+CW%22">Wee CW</searchLink>; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea.; Brain Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yoon+HI%22">Yoon HI</searchLink>; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea.; Brain Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jeon+SH%22">Jeon SH</searchLink>; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+IA%22">Kim IA</searchLink>; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink>; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, the Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, the Republic of Korea. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101713416%22">Clinical and translational radiation oncology</searchLink> [Clin Transl Radiat Oncol] 2026 May 26; Vol. 59, pp. 101197. <i>Date of Electronic Publication: </i>2026 May 26 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ireland+Ltd%2E+on+behalf+of+European+Society+for+Radiotherapy+and+Oncology%22">Elsevier Ireland Ltd. on behalf of European Society for Radiotherapy and Oncology </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>101713416 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2405-6308 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224056308%22">24056308 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Radiat Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42255978 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ctro.2026.101197 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101197 Titles: – TitleFull: Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chun SJ – PersonEntity: Name: NameFull: Kim N – PersonEntity: Name: NameFull: Lim DH – PersonEntity: Name: NameFull: Kim JY – PersonEntity: Name: NameFull: Wee CW – PersonEntity: Name: NameFull: Yoon HI – PersonEntity: Name: NameFull: Jeon SH – PersonEntity: Name: NameFull: Kim IA – PersonEntity: Name: NameFull: Lee JH IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 05 Text: 2026 May 26 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2405-6308 Numbering: – Type: volume Value: 59 Titles: – TitleFull: Clinical and translational radiation oncology Type: main |
| ResultId | 1 |